Link, John O.
Rhee, Martin S.
Tse, Winston C.
Zheng, Jim
Somoza, John R.
Rowe, William
Begley, Rebecca
Chiu, Anna
Mulato, Andrew
Hansen, Derek
Singer, Eric
Tsai, Luong K.
Bam, Rujuta A.
Chou, Chien-Hung
Canales, Eda
Brizgys, Gediminas
Zhang, Jennifer R.
Li, Jiayao
Graupe, Michael
Morganelli, Philip
Liu, Qi
Wu, Qiaoyin
Halcomb, Randall L.
Saito, Roland D.
Schroeder, Scott D.
Lazerwith, Scott E.
Bondy, Steven
Jin, Debi
Hung, Magdeleine
Novikov, Nikolai
Liu, Xiaohong
Villaseñor, Armando G.
Cannizzaro, Carina E.
Hu, Eric Y.
Anderson, Robert L.
Appleby, Todd C.
Lu, Bing
Mwangi, Judy
Liclican, Albert
Niedziela-Majka, Anita
Papalia, Giuseppe A.
Wong, Melanie H.
Leavitt, Stephanie A.
Xu, Yili
Koditek, David
Stepan, George J.
Yu, Helen
Pagratis, Nikos
Clancy, Sheila
Ahmadyar, Shekeba
Cai, Terrence Z.
Sellers, Scott
Wolckenhauer, Scott A.
Ling, John
Callebaut, Christian
Margot, Nicolas
Ram, Renee R.
Liu, Ya-Pei
Hyland, Rob
Sinclair, Gary I.
Ruane, Peter J.
Crofoot, Gordon E.
McDonald, Cheryl K.
Brainard, Diana M.
Lad, Latesh
Swaminathan, Swami
Sundquist, Wesley I.
Sakowicz, Roman
Chester, Anne E.
Lee, William E.
Daar, Eric S.
Yant, Stephen R.
Cihlar, Tomas
Article History
Received: 26 November 2019
Accepted: 14 April 2020
First Online: 1 July 2020
Competing interests
: All authors are current or previous employees of Gilead Sciences (except for G.I.S., P.J.R., G.E.C., C.K.M., W.I.S. and E.S.D.) and received salary and stock ownership as compensation for their employment. M.G., J.O.L., W.R., R.D.S., S.D.S., W.C.T. and J.R.Z. are inventors on granted US patent no. 10,071,985B2 covering GS-6207 composition of matter and methods of use. G.I.S. receives research support from Gilead Sciences, Janssen Pharmaceutica, GlaxoSmithKline, Abbvie and Cepheid, and is on the speaker’s bureau and advisory board for Janssen, ViiV Healthcare and Merck. G.E.C. receives grants (investigator research payments) from Gilead Sciences, ViiV Healthcare, Merck and Janssen Pharmaceutica. C.K.M. receives research support from Gilead Sciences, Merck, ViiV Healthcare and Janssen Pharmaceutica, is on the speaker’s bureau for Gilead Sciences, Merck and Insmed, and is on an advisory board for Gilead Sciences. E.S.D. receives research support from Gilead Sciences, Merck and ViiV Healthcare, and has served as a consultant for Gilead Sciences.